Legislature(2015 - 2016)BARNES 124
04/11/2016 03:15 PM House LABOR & COMMERCE
Note: the audio ![]()
and video ![]()
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB234 | |
| Alaska Workers' Compensation Board | |
| HB271 | |
| SB127 | |
| SB142 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| + | TELECONFERENCED | ||
| += | HB 234 | TELECONFERENCED | |
| += | HB 271 | TELECONFERENCED | |
| += | SB 127 | TELECONFERENCED | |
| += | SB 142 | TELECONFERENCED | |
SB 142-INSURANCE FOR ANTI-CANCER MEDICATION
[Due to technical difficulties, the record from 4:49:46 p.m. to
4:51:39 p.m. was reconstructed from the recording secretary's
log notes.]
4:49:46 PM
CHAIR OLSON announced that the final order of business would be
CS FOR SENATE BILL NO. 142(L&C) am, "An Act relating to
insurance coverage for anti-cancer medications."
[During the meeting of 4/6/16, Amendment 1, labeled 29-
LS1133\W.A.1, Wallace, 4/5/16, was objected to by Representative
LeDoux. Amendment 1 read:
Page 1, line 1, following "medications":
Insert "; and providing for an effective date"
Page 2, following line 14:
Insert a new bill section to read:
"* Sec. 3. This Act takes effect January 1,
2017."]
[Chair Olson stated that he objected to Amendment 1 at the
previous hearing.]
REPRESENTATIVE JOSEPHSON asked Ms. Wing-Heier to elaborate on
her previous testimony regarding an individual's choice of a
pharmacy.
4:51:51 PM
LORI WING-HEIER, Director, Division of Insurance, Department of
Commerce, Community & Economic Development (DCCED), explained
that if an individual goes to a pharmacy [out-of-network] they
will receive a higher copay, which is how the plans are written
within the individual's plan.
REPRESENTATIVE JOSEPHSON observed that an individual may choose
to go to an alternate pharmacy but would risk paying more.
MS. WING-HEIER agreed and stated that if the individual chooses
to go to a pharmacy out-of-network, just as they may choose to
go to a physician out-of-network, there would be a higher copay.
REPRESENTATIVE JOSEPHSON referred to the effective date of the
bill, and recalled testimony regarding the urgency of the
application if the bill becomes law, such as administrative
problems associated with the bill. He asked for clarification
of the effective date shown on page 2, line 12.
MS. WING-HEIER explained that the division must comply with the
effective date of the [Patient Protection and Affordable Care
Act of 2010 (PPACA)], and most of the plans now are dated
January 1. Therefore, the form filings and such have to be May
11, although they can be amended up until mid-August, but the
first form filings are due for the 2017 plans on May 11. The
division is beginning to receive form filings that are affected
by this and other pending bills, thus the division is "squeezed
into this 30-day period for bills that haven't passed, to be
signed, to go to the insurers, to be [put] into plan documents,
to be filed with ... the division, to be approved, and that's
the, the administrative heartache that we're asking for a
revised effective date."
4:53:50 PM
CHAIR OLSON removed his objection to Amendment 1 [and the
committee treated the objection made by Representative LeDoux as
withdrawn.] There being no further objection, Amendment 1 was
adopted.
CHAIR OLSON opened public testimony and after ascertaining no
one wished to testify, closed public testimony.
4:54:34 PM
REPRESENTATIVE TILTON moved to report the committee substitute
for CSSB 142(L&C)am, Version 29-LS1133\W.A, as amended, out of
committee with individual recommendations and the accompanying
zero fiscal notes. There being no objection, HCS CSSB 142(L&C)
was reported out of the House Labor and Commerce Standing
Committee.